Previous close | 15.75 |
Open | 16.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 15.81 - 16.40 |
52-week range | 6.40 - 18.91 |
Volume | |
Avg. volume | 12,285 |
Market cap | 86.952M |
Beta (5Y monthly) | 1.53 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.34 (14.47%) |
Ex-dividend date | 12 Apr 2024 |
1y target est | N/A |
In the last year, multiple insiders have substantially increased their holdings of Fortress Biotech, Inc. ( NASDAQ:FBIO...
On January 5, 2024, ROSENWALD LINDSAY A MD, the President, CEO & Chairman, and 10% Owner of Fortress Biotech Inc, executed a significant stock purchase, acquiring 50,000 shares of the company.
We feel now is a pretty good time to analyse Fortress Biotech, Inc.'s ( NASDAQ:FBIO ) business as it appears the...